Vulnerability Description
A privilege escalation vulnerability exists in Node.js <19.6.1, <18.14.1, <16.19.1 and <14.21.3 that made it possible to bypass the experimental Permissions (https://nodejs.org/api/permissions.html) feature in Node.js and access non authorized modules by using process.mainModule.require(). This only affects users who had enabled the experimental permissions option with --experimental-policy.
CVSS Score
HIGH
Affected Products
| Vendor | Product | Versions |
|---|---|---|
| Nodejs | Node.Js | >= 14.0.0, <= 14.14.0 |
Related Weaknesses (CWE)
References
- https://nodejs.org/en/blog/vulnerability/february-2023-security-releases/PatchVendor Advisory
- https://security.netapp.com/advisory/ntap-20230316-0008/
- https://nodejs.org/en/blog/vulnerability/february-2023-security-releases/PatchVendor Advisory
- https://security.netapp.com/advisory/ntap-20230316-0008/
FAQ
What is CVE-2023-23918?
CVE-2023-23918 is a vulnerability with a CVSS score of 7.5 (HIGH). A privilege escalation vulnerability exists in Node.js <19.6.1, <18.14.1, <16.19.1 and <14.21.3 that made it possible to bypass the experimental Permissions (https://nodejs.org/api/permissions.html) f...
How severe is CVE-2023-23918?
CVE-2023-23918 has been rated HIGH with a CVSS base score of 7.5/10. Review the CVSS metrics above for detailed severity breakdown.
Is there a patch for CVE-2023-23918?
Check the references section above for vendor advisories and patch information. Affected products include: Nodejs Node.Js.